Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi Targeting BBI39

Version 1 : Received: 29 November 2023 / Approved: 30 November 2023 / Online: 30 November 2023 (17:08:25 CET)

A peer-reviewed article of this Preprint also exists.

Rios, S.; Bhattachan, B.; Vavilikolanu, K.; Kitsou, C.; Pal, U.; Schnell, M.J. The Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi, Targeting BBI39. Vaccines 2024, 12, 78. Rios, S.; Bhattachan, B.; Vavilikolanu, K.; Kitsou, C.; Pal, U.; Schnell, M.J. The Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi, Targeting BBI39. Vaccines 2024, 12, 78.

Abstract

Lyme disease is the most common tick-borne illness in the United States, Europe, and Asia. Borrelia burgdorferi, a spirochete bacterium transmitted by the tick vector Ixodes scapularis, causes Lyme disease in the U.S. If untreated, Lyme arthritis, carditis, and meningitis will occur. Given the absence of a human Lyme disease vaccine, we developed a vaccine using the rabies virus vaccine vector, BNSP333, and an outer surface borrelial protein BBI39. To incorporate BBI39 into the RABV virion, we generated a chimeric BBI39 antigen, BBI39RVG, by fusing it with the final amino acids of the RABV glycoprotein. Here we demonstrated that BBI39RVG antigen was incorporated into the RABV virion, and mice vaccinated with our RABV-BBI39RVG vaccine induced high amounts of BBI39-specific antibodies which are maintained long-term. The BBI39 antibodies neutralized Borrelia in vaccinated mice when challenged with Borrelia burgdorferi by either syringe injection or infected ticks, and reduced Lyme disease pathology.

Keywords

Lyme disease vaccine; borrelia burgdorferi; rabies virus; viral vaccine vectors

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.